ArticleOphthalmology and therapy2023

Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study.

Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.